Case File
efta-efta01582883DOJ Data Set 10CorrespondenceEFTA Document EFTA01582883
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01582883
Pages
0
Persons
0
Integrity
Loading PDF viewer...
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
Officers, Directors:
JEFFREY E EPSTEIN
P/D
358 EL BRILLO WAY
PALM. BEACH, FL 3348C
AMANDA J ELLISON
SECRETARY
457 MADISON AVENUE
NEW YORK, NY 10022
History:
File Date: 10/23/1998
Type: VOLUNTARY DISSOLUTION
File Date: 4/21/1995
Type: AMENDMENT AND NAME CHANGE
Comments: Name Changed To: GHISLAINE CORP.
[PAGE
Confidential Treatment Requested by JPMorgan Chase
JPM-SDNY-00062464
EFTA01582883
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.